News On Mateon Therapeutics Inc. (MATN) Now Under OTLC

Dow Jones NewswiresApr 1, 2021 05:09

Mateon Therapeutics Initiated at Buy by Litchfield Hills

Dow Jones NewswiresDec 7, 2020 20:35

Litchfield Hills Initiates Coverage On Mateon Therapeutics with Buy Rating, Announces Price Target of $3

Benzinga Real-time NewsDec 7, 2020 20:25

Mateon Therapeutics analyst ratings

Benzinga Analyst RatingsDec 7, 2020 20:24

BRIEF-Mateon Therapeutics Inc Says First Patient Enrolled This Week In Its Phase IV Study

ReutersOct 7, 2020 19:43

FDA Grants Pediatric Disease Designation for Mateon's CA4P

道琼斯May 5, 2020 18:55